Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
about
Tertiary Lymphoid Organs in Cancer TissuesPredictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancerA miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change afReliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signalingPrognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value.Association between PD-L1 expression combined with tumor-infiltrating lymphocytes and the prognosis of patients with advanced hypopharyngeal squamous cell carcinoma.The Predictive and Prognostic Role of Stromal Tumor-infiltrating Lymphocytes in HER2-positive Breast Cancer with Trastuzumab-based Treatment: a Meta-analysis and Systematic Review.FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment.Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes.MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers.Mechanisms of immune evasion in breast cancer.Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line
P2860
Q26742168-708C6FEB-D31E-409B-BDDF-C1F1A4891A0CQ33584033-BA257FC4-89A9-461F-A679-A626CAEA825AQ33584106-D41D07F8-7BA5-4477-885F-ADF109D3E489Q33779333-90B2A12C-099C-41C8-9275-865DC577C85AQ37271711-F3871B9B-ADC8-4646-9E92-9C2B6E080109Q37536862-F80CE53C-D0C0-4A9E-982D-44B440F6273AQ37616487-1A152C39-0F3D-414F-ACD1-17AC78267C75Q38411841-CF60295A-FF71-46B7-86B8-B9D19646F6C8Q38670277-D0C66DB7-350D-4BA4-A8B8-3DC96AA8143BQ38775011-4EC87C1B-E659-4ED4-852A-72DFE0D10032Q38888197-6E08EE2D-E69F-492E-89C0-34A43066DB26Q39245218-728DBBC6-290F-4F80-B532-71A0646552A9Q41718196-844A3DD2-19D7-4C80-AEC9-34327E121A71Q46067261-CB030C1B-3C92-4CA2-A6D0-F3502644BD3BQ47109695-6D0D2C56-C03E-48BB-AAD4-4F6B3571997CQ52599656-0AC8347B-A46D-4B89-A1AE-AF196EAD926DQ52763518-F42DA362-ED76-412D-99C2-F87282C82D86Q53067561-E341C00D-3F7E-4F59-A637-B6054E661F00Q53122691-FF31498F-3841-4A95-9928-F881697640E5Q53166472-96B2617C-6160-4AC1-9336-6F21BE3E604EQ53170218-8BEF152A-09AD-4D91-A605-209413C450EAQ53192082-14EA560F-E207-405F-955E-A631630B189CQ55347716-8F824DD9-5414-4A40-9590-765B38A1760DQ57175799-4F4635A0-C989-4AC5-9953-D079C05CB5D7
P2860
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic Significance of Tum ...... ted With Adjuvant Trastuzumab.
@en
type
label
Prognostic Significance of Tum ...... ted With Adjuvant Trastuzumab.
@en
prefLabel
Prognostic Significance of Tum ...... ted With Adjuvant Trastuzumab.
@en
P2093
P2860
P356
P1476
Prognostic Significance of Tum ...... ted With Adjuvant Trastuzumab.
@en
P2093
Gyungyub Gong
Hee Jin Lee
In Ah Park
In Hye Song
Jin-Hee Ahn
Jong Han Yu
Joo Young Kim
P2860
P304
P356
10.1309/AJCPIXUYDVZ0RZ3G
P407
P577
2015-08-01T00:00:00Z